Drug intelligence / Profile preview

GelART

Development stage
Unknown
Lead developer
Shibuya
Modality
Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Surgical Epicardial Application
01

Overview

GelART is a biomaterial composed of gelatin hydrogel particles developed by Shibuya Kogyo in collaboration with Professor Yasuhiko Tabata. It is specifically designed to serve as a scaffold for cell transplantation in regenerative medicine. The hydrogel particles provide a supportive microenvironment that enhances the engraftment, retention, and viability of transplanted cells, thereby improving the overall therapeutic efficacy of the treatment. GelART is utilized as a critical component in iHeart Japan's IHJ-301, an iPSC-derived cardiomyocyte patch for treating dilated cardiomyopathy. The product has been recognized by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its suitability as a raw material in regenerative medicine products.

Brand names
GelART
Other names
gelatin hydrogel particlesゼラチンハイドロゲル粒子

Beyond the preview

Go deeper on GelART.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GelART.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call